GUANABENZ-CONTAINING COMPOUND FOR THE TREATMENT OF PRIMARY CUTANEOUS AMYLOIDOSIS

摘要

This invention refers to the pharmaceutical composition with guanabenz as active ingredient and is indicated for the treatment of primary cutaneous amyloidosis. The composition of this invention can be supplied as cream, gel, jelly cream, ointment, lotion or any other dosage form intended for topical use. The effect of guanabenz on the anomalous proteins that cause primary cutaneous amyloidosis, according to this invention, is not related to the action of this drug as alpha-2 adrenergic agonist, as is the case for the other indications of this substance according to the state of the art.